These Numbers Show Favorable Signs for Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is -48.28% lower on its value in year-to-date trading and has touched a low of $1.69 and a high of $24.01 in the current 52-week trading range. The MIST stock was last observed hovering at around $8.91 in the last trading session, with the day’s loss setting it -0.63%.

5 Stocks to make up the PERFECT 2021 gold portfolio

Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.

Click here to download your free report right away


Currently trading at $8.28, the stock is 111.55% and 117.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 53.13 million and changing -7.07% at the moment leaves the stock -30.44% off its SMA200. MIST registered -57.54% loss for a year compared to 6-month loss of -61.18%. The firm has a 50-day simple moving average (SMA 50) of $4.16 and a 200-day simple moving average (SMA200) of $9.33.

The stock witnessed a 100.00% gain in the last 1 month and extending the period to 3 months gives it a 266.37%, and is 133.24% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 24.57% over the week and 10.98% over the month.

Distance from 52-week low is 389.94% and -65.51% from its 52-week high.

Milestone Pharmaceuticals Inc. (MIST) Analyst Forecasts

Milestone Pharmaceuticals Inc. quarterly earnings per share for the current quarter are estimated at -$0.46.The EPS is expected to shrink by -256.90% this year.

Milestone Pharmaceuticals Inc. (MIST) Top Institutional Holders

29 institutions hold shares in Milestone Pharmaceuticals Inc. (MIST), with 1.71M shares held by insiders accounting for 6.96% while institutional investors hold 77.85% of the company’s shares. The shares outstanding are 24.55M, and float is at 21.77M with Short Float at 6.08%. Institutions hold 72.43% of the Float.

The top institutional shareholder in the company is RTW Investments LP with over 4.32 million shares valued at $7.94 million. The investor’s holdings represent 17.52% of the MIST Shares outstanding. As of Mar 30, 2020, the second largest holder is Novo Holdings A/S with 2.08 million shares valued at $3.83 million to account for 8.45% of the shares outstanding. The other top investors are Boxer Capital, LLC which holds 1.1 million shares representing 4.48% and valued at over $2.03 million, while Price (T.Rowe) Associates Inc holds 2.37% of the shares totaling 0.58 million with a market value of $1.08 million.

Milestone Pharmaceuticals Inc. (MIST) Insider Activity

A total of 5 insider transactions have happened at Milestone Pharmaceuticals Inc. (MIST) in the last six months, with sales accounting for 0 and purchases happening 5 times. The most recent transaction is an insider purchase by RTW INVESTMENTS, LP, the company’s 10% Owner. SEC filings show that RTW INVESTMENTS, LP bought 5,870 shares of the company’s common stock on Mar 19 at a price of $10.87 per share for a total of $63804.0. Following the purchase, the insider now owns 4.32 million shares.

Milestone Pharmaceuticals Inc. disclosed in a document filed with the SEC on Mar 18 that RTW INVESTMENTS, LP (10% Owner) bought a total of 2,705 shares of the company’s common stock. The trade occurred on Mar 18 and was made at $10.36 per share for $28029.0. Following the transaction, the insider now directly holds 4.31 million shares of the MIST stock.

Still, SEC filings show that on Mar 02, RTW INVESTMENTS, LP (10% Owner) acquired 78,263 shares at an average price of $18.95 for $1.48 million. The insider now directly holds 4,306,527 shares of Milestone Pharmaceuticals Inc. (MIST).

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free